| Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis S Torres, C Ortiz, N Bachtler, W Gu, LD Grünewald, N Kraus, ... Hepatology 77 (4), 1228-1240, 2023 | 9 | 2023 |
| Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1 C Ortiz, S Klein, WH Reul, F Magdaleno, S Gröschl, P Dietrich, ... Cell Reports 42 (2), 2023 | 6 | 2023 |
| The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells N Bachtler, S Torres, C Ortiz, R Schierwagen, O Tyc, C Hieber, ML Berres, ... Plos one 18 (1), e0270288, 2023 | 5 | 2023 |
| Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice E Dorochow, N Kraus, N Chenaux-Repond, S Pierre, A Kolbinger, ... International journal of molecular sciences 24 (12), 10351, 2023 | 3 | 2023 |
| Higher prevalences and titers of CMV, EBV and HSV1 viremia in patients with acute-on-chronic liver failure derived from the ACLF-I cohort J Sonnenberg, K Thiyagarajah, E Görgülü, M Glitscher, T Wiedemann, ... Zeitschrift für Gastroenterologie 62 (01), P5. 20, 2024 | 1 | 2024 |
| New Rat Model of Cholestatic Liver Cirrhosis Developing Acute-on-Chronic-Liver failure N Kraus, M Moeslein, R Schierwagen, C Ortiz, S Torres, O Tyc, C Hieber, ... Zeitschrift für Gastroenterologie 60 (01), P 1.14, 2022 | 1 | 2022 |
| New Rat Model of Alcoholic Liver Cirrhosis Developing Acute-on-Chronic-Liver failure N Kraus, FE Uschner, M Moeslein, R Schierwagen, C Ortiz, S Torres, ... Zeitschrift für Gastroenterologie 60 (01), P 1.15, 2022 | 1 | 2022 |
| BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes L Alcober-Boquet, N Kraus, LS Huber, R Vutukuri, DC Fuhrmann, ... American Journal of Physiology-Cell Physiology 326 (3), C880-C892, 2024 | | 2024 |
| The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure MM Mücke, N El Bali, KM Schwarzkopf, FE Uschner, N Kraus, L Eberle, ... International Journal of Molecular Sciences 25 (3), 1542, 2024 | | 2024 |
| ACCELERATION OF AN ADVANCED NASH MODEL BY ACUTE AND TOXIC EFFECTS OF PHENOBARBITAL N Kraus, M Moeslein, R Schierwagen, W Gu, MJ Brol, FE Uschner, ... HEPATOLOGY 78, S1065-S1065, 2023 | | 2023 |
| Charakterisierung neuer Tiermodelle des akut-auf-chronischen Leberversagens FE Uschner, RF Costa, N Kraus, M Moeslein, R Schierwagen, W Gu, ... Zeitschrift für Gastroenterologie 61 (08), KV087, 2023 | | 2023 |
| Development and characterization of novel rodent ACLF models FE Uschner, RF Costa, N Kraus, M Möslein, R Schierwagen, W Gu, ... BDL 250, 4, 2023 | | 2023 |
| Acceleration of an advanced NASH model by acute and toxic effects of Phenobarbital S Klein, N Kraus, M Moeslein, R Schierwagen, W Gu, MJ Brol, ... Zeitschrift für Gastroenterologie 61 (01), P1. 23, 2023 | | 2023 |
| Combination of CCL4-induced decompensated cirrhosis with acute polymicrobial peritonitis as an optimized experimental model mimicking extrahepatic organ failures defined in ACLF R Flores-Costa, A Salvatella, BJ Contreras, M Duran-Güell, M Casulleras, ... Journal of Hepatology 77, S362, 2022 | | 2022 |
| JANUS KINASE 2 INHIBITION BY PACRITINIB IS A POTENTIAL THERAPEUTIC TARGET FOR LIVER FIBROSIS AND PORTAL HYPERTENSION ST Nunez, N Bachtler, C Ortiz, N Kraus, R Schierwagen, C Hieber, ... HEPATOLOGY 74, 822A-823A, 2021 | | 2021 |
| Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer R Schierwagen, P Dietrich, J Heinzen, S Klein, FE Uschner, C Ortiz, O Tyc, ... bioRxiv, 2021.09. 08.458161, 2021 | | 2021 |
